Jean Leclerc Raphael, MD, MPH
Department or Service
- Texas Medical Center
- Specialty Care
Phone: 832-822-3436 (Main) | 346-227-7275 (Palm)
- Sickle Cell Disease
Associate Professor, Department of Pediatrics, Section of Hematology-Oncology and Section of Academic General Pediatrics, Baylor College of Medicine
|Harvard School of Public Health||other||Master of Public Health||2006|
|Children's Hospital Boston||residency||Pediatrics||2005|
|Children's Hospital Boston||residency||Pediatrics||2004|
|Children's Hospital Boston||internship||Pediatrics||2002|
|Harvard Medical School||medical school||Doctor of Medicine||2001|
|Commonwealth Fund Harvard University||fellowship||Minority Health Policy|
He completed Pediatric Residency Training at the Boston Combined Residency in Pediatrics (Children's Hospital Boston/Boston Medical Center) and subsequently obtained advanced training in health disparities in the Commonwealth Fund Harvard University Fellowship in Minority Health Policy while concurrently earning a Master of Public Health in 2006. He was invited to join the faculty at Baylor College of Medicine in July 2006 with a primary appointment in Academic General Pediatrics and secondary appointment in Hematology/Oncology.
Dr. Jean Raphael is a physician for the Sickle Cell Program at Texas Children’s Hematology Center. He is board certified in pediatrics by the American Board of Pediatrics.
|Academic Pediatrics Association||Member|
|American Academy of Pediatrics (AAP)||Member|
|American College of Physician Executives||Member|
|American Public Health Association||Member|
|American Society of Hematology (ASH)||Member|
|Texas Pediatric Society||Member|
Jean Raphael is a board-certified pediatrician and promising early stage investigator who has developed a research program focused on developing behavioral interventions to addressing health disparities among low-income racial/ethnic minority children. He has specifically used sickle cell disease as model of addressing minority health.
Dr. Jean Raphael's research interests are in transcranial doppler screening in sickle cell populations, quality improvement in sickle cell disease, and health disparities.
Dr. Raphael currently has 80% effort dedicated to research with 20% effort for clinical teaching. He has been the principal investigator on a number of grants focused on minority health. Most relevant to this proposal, he has 13 articles published on pediatric sickle cell disease and 5 others focused on pediatric health disparities.
Dr. Raphael seeks to become an independent, NIH-funded clinician-scientist and is uniquely qualified to lead this interdisciplinary research team in conducting the proposed project to develop a text messaging intervention to improve adherence to hydroxyurea among African-American children with sickle cell disease.